|
Aadi Bioscience, Inc. (AADI) DCF Valuation
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Aadi Bioscience, Inc. (AADI) Bundle
Explore Aadi Bioscience, Inc.'s (AADI) financial prospects with our user-friendly DCF Calculator! Enter your assumptions regarding growth, margins, and expenses to calculate Aadi Bioscience, Inc.'s (AADI) intrinsic value and enhance your investment approach.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .7 | 14.0 | 1.0 | 15.2 | 24.4 | 34.5 | 49.0 | 69.4 | 98.5 | 139.6 |
| Revenue Growth, % | 0 | 1769.16 | -92.86 | 1421.6 | 60.06 | 41.8 | 41.8 | 41.8 | 41.8 | 41.8 |
| EBITDA | -24.4 | -2.5 | -109.1 | -60.1 | -65.4 | -28.9 | -40.9 | -58.0 | -82.3 | -116.7 |
| EBITDA, % | -3263.56 | -17.75 | -10914.7 | -395.14 | -268.4 | -83.55 | -83.55 | -83.55 | -83.55 | -83.55 |
| Depreciation | .1 | .2 | .3 | .2 | .2 | 2.8 | 4.0 | 5.7 | 8.0 | 11.4 |
| Depreciation, % | 10.21 | 1.26 | 27.6 | 1.04 | 0.69393 | 8.16 | 8.16 | 8.16 | 8.16 | 8.16 |
| EBIT | -24.5 | -2.7 | -109.4 | -60.3 | -65.5 | -28.9 | -41.0 | -58.2 | -82.5 | -117.0 |
| EBIT, % | -3273.78 | -19.01 | -10942.3 | -396.18 | -269.09 | -83.8 | -83.8 | -83.8 | -83.8 | -83.8 |
| Total Cash | 38.5 | 4.5 | 149.0 | 172.6 | 108.8 | 29.8 | 42.3 | 60.0 | 85.0 | 120.6 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | 14.1 | .0 | 1.9 | 5.5 | 9.3 | 13.2 | 18.7 | 26.5 | 37.6 |
| Account Receivables, % | 0 | 101.06 | 0 | 12.24 | 22.53 | 26.95 | 26.95 | 26.95 | 26.95 | 26.95 |
| Inventories | -.3 | .0 | .0 | 1.9 | 6.4 | .0 | .1 | .1 | .1 | .2 |
| Inventories, % | -38.04 | 0 | 0 | 12.23 | 26.39 | 0.11672 | 0.11672 | 0.11672 | 0.11672 | 0.11672 |
| Accounts Payable | .4 | 2.4 | 6.4 | 3.5 | 5.9 | 15.4 | 21.9 | 31.0 | 43.9 | 62.3 |
| Accounts Payable, % | 58.72 | 17.09 | 643.9 | 23.13 | 24.22 | 44.63 | 44.63 | 44.63 | 44.63 | 44.63 |
| Capital Expenditure | -.2 | .0 | .0 | -.4 | -4.0 | -3.8 | -5.4 | -7.7 | -10.9 | -15.5 |
| Capital Expenditure, % | -31.64 | 0 | -4.6 | -2.92 | -16.31 | -11.09 | -11.09 | -11.09 | -11.09 | -11.09 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -24.5 | -2.7 | -109.4 | -56.8 | -65.5 | -28.6 | -40.6 | -57.5 | -81.6 | -115.6 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -24.0 | -15.0 | -91.0 | -63.7 | -75.2 | -17.5 | -39.5 | -56.0 | -79.3 | -112.5 |
| WACC, % | 6.37 | 6.37 | 6.37 | 6.35 | 6.37 | 6.36 | 6.36 | 6.36 | 6.36 | 6.36 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -242.5 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -115 | |||||||||
| Terminal Value | -2,631 | |||||||||
| Present Terminal Value | -1,932 | |||||||||
| Enterprise Value | -2,175 | |||||||||
| Net Debt | -62 | |||||||||
| Equity Value | -2,113 | |||||||||
| Diluted Shares Outstanding, MM | 27 | |||||||||
| Equity Value Per Share | -78.51 |
What You Will Get
- Real AADI Financial Data: Pre-filled with Aadi Bioscience's historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Aadi Bioscience’s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Customizable Clinical Inputs: Adjust essential parameters such as patient demographics, treatment efficacy, and cost structures.
- Instant Valuation Metrics: Automatically computes intrinsic value, NPV, and various financial outputs in real-time.
- High-Precision Analytics: Incorporates Aadi Bioscience's actual financial data for accurate valuation assessments.
- Effortless Scenario Testing: Easily explore different hypotheses and analyze their impacts side by side.
- Efficiency Booster: Streamline the valuation process without the hassle of creating intricate models from the ground up.
How It Works
- Step 1: Download the prebuilt Excel template with Aadi Bioscience’s data included.
- Step 2: Explore the pre-filled sheets and understand the key metrics.
- Step 3: Update forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly view recalculated results, including Aadi Bioscience’s intrinsic value.
- Step 5: Make informed investment decisions or generate reports using the outputs.
Why Choose Aadi Bioscience's Calculator?
- Comprehensive Tool: Features DCF, WACC, and financial ratio analyses tailored for Aadi Bioscience, Inc. (AADI).
- Customizable Inputs: Modify yellow-highlighted cells to explore different financial scenarios.
- Detailed Insights: Automatically computes Aadi Bioscience’s intrinsic value and Net Present Value.
- Preloaded Data: Utilizes historical and forecasted data for precise calculations.
- Professional Quality: Perfect for financial analysts, investors, and business consultants focused on Aadi Bioscience, Inc. (AADI).
Who Should Use This Product?
- Investors: Accurately estimate Aadi Bioscience's fair value before making investment decisions.
- CFOs: Leverage a professional-grade DCF model for financial reporting and analysis specific to Aadi Bioscience (AADI).
- Consultants: Quickly adapt the template for valuation reports related to Aadi Bioscience (AADI) for clients.
- Entrepreneurs: Gain insights into financial modeling techniques utilized by leading biotech firms.
- Educators: Use it as a teaching tool to demonstrate valuation methodologies in the biotech sector.
What the Template Contains
- Pre-Filled DCF Model: Aadi Bioscience’s financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Aadi Bioscience’s profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.